• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Coverage from IACFS/ME Florida conference, 27-30 Oct 2016

Denise

Senior Member
Messages
1,095
While very serious, I don't know if one can say that the zero applications from young researchers is unique to us.

Nature currently has a series of editorials and articles about the difficulties facing young scientists.
This material could be useful background info ahead of discussions with legislators, NIH, HHS, etc.
The plight of young scientists
A special issue explores how the research enterprise keeps early-career scientists
from pursuing the most important work, and what can be done to help.



 
Workshop:

What happens NOW when someone has ME/CFS?

1. There is a lack of sense of community belonging because:
- the public and institution are disbelieving;
- their health needs are unmet
- they have difficulty getting access to benefits (eg income support, medical benefits, accommodations, homecare)
- the suffer both physical and social isolation

2. ME/CFS is a stigmatised illness:
- Three forms of stigma
* Structural - being public and private institutions (eg government, health care, medical & academic) - this results in neglect, poor policies, widespread misinformation and unfavourable insurance policies)
* Public - being negative social norms, educators, medical providers, employers, media, legislation - this results in disbelief, mistreatment by medical practitioners, accommodations are lacking, and media reinforce stigma
* Self-Stigma - being a reaction to rejection, disbelief, nondisclosure of the disease due to fear of mistreatment - this results in isolation and barriers to treatment

3. Unmet Health Care Needs:
- Attitudes of medical providers are poor
- there is a shortage of accessible, knowledgeable medical providers
- there are problems with diagnosis/lack of diagnosis
- there is a lack of treatment and problems access treatments
- there are cost issues (in visiting offices, getting tests, obtaining treatments)

3A - Attitudes and beliefs of Medical Providers
The US National Academy of Medicine Report:
* the health care community generally still doubts the existence and seriousness of the condition
* the patients report hostility within health care provider attitudes
* the barriers to timely and appropriate diagnosis is one of attitude, more than knowledge.

3B - Diagnostic Issues
- there are misperceptions about the disease
- there is a non-specific criteria
* doesn't require the hallmark symptoms
* the key symptoms of the disease are not defined or understood
- There is an overlap with other conditions
* this contributes to misdiagnosis and inappropriate treatment
- there is an importance to differential diagnosis

3C - Inappropriate Treatment
- there is no treatment for the key symptoms
- the guidelines are inappropriate and can do harm
- there is a failure to recognise and treat subsequent disease that arise (eg cancer, cardiovascular, etc)

3 D - Cost/Payment for Services
In the US experience:
- Insurance coverage varies between companies and state
- Insurance doesn't reimburse longer visits
- There is limited or no cover for tests and treatments
 
Workshop

The Workshop moved into the question of what SHOULD happen?

1. Accessible clinical care
2. Good clinical care for diagnosis and treatment supported by research
3. Good access to disability supports
4. Social support, understanding and accommodations.

The potential approach was informed by the Inflammatory Arthritis Model of Care.
1. Identification
2. Access
3. Medical Management
4. Shared care

What is needed in ME/CFS to implement this model?
- patients need to know to seek care, and need to be comfortable in doing so
- Primary Care Physicians (PCP's) need to respond with support and make appropriate referrals
- Specialists need to be available and accessible
- Specialists need to provide treatment and monitor the patient on an ongoing basis
- Partnership need to be in place - to deal with comorbidities, provide treatments, and assist with disability benefits
- the performance of this system will need to be monitored
- someone will need to pay for all this

Access to knowledgeable Medical Providers (Specialists/GP's)
Using the Canadian Experience:
- there are about 80,000 doctors
- there are 40,000 primary care physicians
- there are about 30,000 specialists and 10,000 surgeons
- there are a variety of specialities, including internal medicine, neurology, paediatrics, anesthesiology, psychiatry, etc

So who should handle ME/CFS? Which speciality structure is appropriate? How many doctors are needed.

* The narrative NEEDS to change
* Appropriate clinical guidance and active dissemination in addition to stigma busting
* centres for excellence - the CFSAC Recommendation is a starting point
* Current NIH plan - Consortia
* Other ideas to increase provider capacity
 

Kati

Patient in training
Messages
5,497
Workshop

The Workshop moved into the question of what SHOULD happen?

1. Accessible clinical care
2. Good clinical care for diagnosis and treatment supported by research
3. Good access to disability supports
4. Social support, understanding and accommodations.

The potential approach was informed by the Inflammatory Arthritis Model of Care.
1. Identification
2. Access
3. Medical Management
4. Shared care

What is needed in ME/CFS to implement this model?
- patients need to know to seek care, and need to be comfortable in doing so
- Primary Care Physicians (PCP's) need to respond with support and make appropriate referrals
- Specialists need to be available and accessible
- Specialists need to provide treatment and monitor the patient on an ongoing basis
- Partnership need to be in place - to deal with comorbidities, provide treatments, and assist with disability benefits
- the performance of this system will need to be monitored
- someone will need to pay for all this

Access to knowledgeable Medical Providers (Specialists/GP's)
Using the Canadian Experience:
- there are about 80,000 doctors
- there are 40,000 primary care physicians
- there are about 30,000 specialists and 10,000 surgeons
- there are a variety of specialities, including internal medicine, neurology, paediatrics, anesthesiology, psychiatry, etc

So who should handle ME/CFS? Which speciality structure is appropriate? How many doctors are needed.

* The narrative NEEDS to change
* Appropriate clinical guidance and active dissemination in addition to stigma busting
* centres for excellence - the CFSAC Recommendation is a starting point
* Current NIH plan - Consortia
* Other ideas to increase provider capacity

Thank you... this is crucial.
 

Never Give Up

Collecting improvements, until there's a cure.
Messages
971
Hi Guys .... I am currently at the conference. We have just had an introduction from Fred Friedberg who has outlined the conference for the next four days, and particularly to speakers and workshops for today.

Currently listening to Vicky Whittemore from the NIH who has provided an extensive outline of the NIH approach to ME/CFS Research.

Of significance is the fact that the NIH has never had an application from a young researcher for an NIH grant for ME/CFS. They have put this down to the fact that researchers were scared away from the field. They are actively encouraging grant applications in this area in order to build the research pool.

Internationally speaking, the NIH is looking to develop collaboration and provide funding to international research.

NIH Website: www.nih.gov/mecfs

NIH are doing a grant research workshop this afternoon to look at how to be successful at grant applications to the NIH
Do they believe young researchers are being scared away by the complexity of the disease or the behavior of some patients?
 

Timaca

Senior Member
Messages
792
I attended yesterday (patient conference). I don't have much time to type (sorry for the typos--I won't correct them) and have not read the other comments, nor will I have time to read replies since I'm at the conference but here is what I enjoyed and/or heard:

Dan Peterson mentioned several current areas of study: (missed the first one), Anakinra, Rituximab, Cyclophopamide, LDN, High dose B12 (open medicine institute), Fecal Microbiota transplant.

God bless the Norwegians for their work. Most exciting was their new study using cyclophopamide which was proving to be quite helpful. They were surprised to see that ME patients got more sick taking the drug than the cancer patients! They are very encouraged by the results of this study that is ongoing.

Lily Chu gave a great talk on how to prepare for doctor's visits. I may share more later as time allows.

Jarrod Younger did not recommend opiods for pain control. He suggested trying alternatives such as curcumin or LDN. Some doctors were using LDN up to 10 (didn't get the units, sorry...but whatever it is for 4.5.... :)

John Kaiser presented in a breakout session. He suggested getting into the parasympathetic state....a healing time every day. He felt that restorative yoga, times of silence or mediation were all important to healing. Pacing, and not doing more than you can was also advised. He helped develop K-PAX,,,,supplements for the mitochondria. Check out the website.

Lucunda BAteman discussed fibromyalgia as did Jarrod Younger. He gave the top 9 studies done on FM in 2016. If those haven't been discussed, maybe I can get around to that.

With regard to LDN, they suggested getting to your target dose (personalized) and staying there for 2 months (Younger) or 3 months (Batemen) to see if it is working for you.

That's it. :) I am excited that there are so many bright minds thinking on these illnesses!

Best,